MedTrace Logo

BetterInfo on Women's PrEP Choices and Outcomes in Malawi

NCT07579754 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 384

Last updated 2026-05-12

No results posted yet for this study

Summary

The purpose of this study is to understand PrEP user choices, preferences and implementation impact of the roll-out of long-acting injectable PrEP alongside oral PrEP among women in Blantyre, Malawi.

Conditions

  • Long-acting Injectable Cabotegravir for PrEP
  • Oral Pre-Exposure Prophylaxis (PrEP)

Interventions

BEHAVIORAL

Tracing Strategy

Participants will receive the SoC per national guidelines and the tracing strategy. The purpose of this intervention is to ascertain the PrEP outcome of clients who have become LTFU (3 months late for a follow-up visit. The strategy includes 1) phone tracing and 2) field tracing with consent.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Kamuzu University of Health Sciences

    collaborator OTHER

  • Johns Hopkins Research Project, Malawi

    collaborator UNKNOWN

  • Washington University School of Medicine

    collaborator OTHER

  • Johns Hopkins Bloomberg School of Public Health

    lead OTHER

Principal Investigators

  • Sheree Schwartz, PhD, MPH · Johns Hopkins Bloomberg School of Public Health

  • Linda Nyondo-Mipando, PhD, RNM · Kamuzu University of Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2028-04-30
Completion
2029-04-30

Countries

  • Malawi

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07579754 on ClinicalTrials.gov